Osteoporosis Clinical Trial
— STARKOfficial title:
Efficacy of the STARK Comprehensive Autonomy Health Care Package in Functional Recovery After a Hip Fracture: A Randomized Controlled Trial
NCT number | NCT03154684 |
Other study ID # | 2016-01820 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | May 5, 2017 |
Est. completion date | August 15, 2021 |
Verified date | August 2021 |
Source | University of Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary purpose of this study is to test if the STARK comprehensive autonomy health care package improves lower extremity function over time at 6 weeks, 3, 6 and 12 months after hip or pelvis fracture compared to the standard of care.
Status | Terminated |
Enrollment | 5 |
Est. completion date | August 15, 2021 |
Est. primary completion date | August 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility | Inclusion Criteria: - Community-dwelling prior to the hip fracture event - Living alone or with a partner/family member - Living in the city of Zurich - age 70+ - Acute hip or pelvis fracture after minimal trauma (resulting from a fall occurring from a standard height and without the involvement of others or a vehicle) - Living at home without or with minimal (i.e. no more than 1x/day) support from the Spitex (ambulant nursing service) before the hip fracture - Participant is mentally competent (judicious) based on the treating physicians' opinion at the screening visit. - Inpatient rehabilitation or inpatient transitional care at a nursing home or ambulatory standard of care - The participant understands the study procedures and voluntarily agree to participate in the study and comply with all its procedures by giving written informed consent Exclusion Criteria: - Patients who are expected to return home without help (i.e. no more care than Spitex 1x/day or physiotherapy 2x/week needed) directly after acute care are excluded. - Conservative treatment of acute hip fracture or surgical treatment that does not allow full weight bearing after surgery - Currently under cancer treatment or has active cancer (except for non-melanoma skin cancer) - Major visual or hearing impairment (visual and/or hearing aids are allowed) or other serious illness that would preclude participation - 24-hour nursing care need as this cannot be offered within the STARK package - Mobility impairment that precludes return to own apartment - Planned nursing home admission after acute hospital stay - Current participation in another clinical trial, or plans of such participation in the next 12 months (corresponding to the study duration) - Inability to read and/or speak German to an extent necessary to understand instructions and participate in the study - Unwilling to forego any additional vitamin D supplementation (bolus or regular intake). |
Country | Name | City | State |
---|---|---|---|
Switzerland | Dept. of Geriatrics and Aging Research, University of Zurich / Geriatric Clinic University Hospital Zurich | Zürich | ZH |
Lead Sponsor | Collaborator |
---|---|
University of Zurich | City of Zurich, Switzerland, Ebnet Stiftung, Switzerland, Spitex Zürich, Switzerland, University Hospital, Zürich, University of Applied Sciences of Western Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Interaction of family carer with hip-fracture patient and health professionals | The interaction will be assessed by semi-structured interviews with a family carer. | 12 months | |
Primary | Lower extremity function | Lower extremity function will be measured by the Short Physical Performance Battery (SPPB) | 12 months | |
Secondary | Gait speed | Gait speed will be obtained from the SPPB. | 12 months | |
Secondary | Gait speed | Gait speed will be assessed by a 400 m walk test. | 12 months | |
Secondary | Grip strength | Hand grip strength will be measured using a Martin Vigorimeter. | 12 months | |
Secondary | Repeated sit-to-stand | Repeated chair stand test will be obtained from the SPPB. | 12 months | |
Secondary | Rate of falls | Rate of falls will be assessed by a monthly phone call. | 12 months | |
Secondary | Health care utilization | Health care utilization will be assessed using the health care utilization questionnaire. | 12 months | |
Secondary | Number of re-hospitalizations | All hospitalizations will be documented as part of the safety documentation(SAE). | 12 months | |
Secondary | Number of nursing home admissions | All nursing home admissions will be documented. | 12 months | |
Secondary | Adherence to preventive strategies | Adherence will be documented by the Spitex staff. | 3 months | |
Secondary | Adherence to preventive strategies | Adherence will be documented by an adherence questionnaire. | 12 months | |
Secondary | Quality of life | Quality of life will be assessed by the RAND SF-36 questionnaire. | 12 months | |
Secondary | Quality of life | Quality of life will be assessed by the EuroQol (EQ-5D-3L) questionnaire. | 12 months | |
Secondary | Cognitive function | Cognitive function will be assessed by the MoCA. | 12 months | |
Secondary | Cognitive function | Cognitive function will be assessed by the MMSE. | 12 months | |
Secondary | Appendicular muscle mass | Appendicular muscle mass will be assessed by dual energy X-ray absorptiometry. | 12 months | |
Secondary | Bone mineral density | Bone mineral density will be assessed by dual energy X-ray absorptiometry. | 12 months | |
Secondary | Activities of daily living | Activities of daily living will be assessed by questionnaire (PROMIS-HAQ) | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
Completed |
NCT02143674 -
Muscle Strengthening Exercises and Global Stretching in Elderly
|
N/A |